🇺🇸 FDA
Patent

US 6287562

Methods of inhibiting the growth of cells bearing LewisY antigens using B1, B3, or B5 targeted immunoconjugates

expired A61KA61K38/00A61K47/6851

Quick answer

US patent 6287562 (Methods of inhibiting the growth of cells bearing LewisY antigens using B1, B3, or B5 targeted immunoconjugates) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The United States of America, as represented by the Department of Health and Human Services
Grant date
Tue Sep 11 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 06 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
16
CPC classes
A61K, A61K38/00, A61K47/6851, A61P, A61P35/00